Trial intelligence / Profile preview

Cinnopar for distal radius fracture healing

IRCT20180526039837N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Feb 2017
Modality
Peptides
Countries
1
01

Overview

Phase 3, single-blind trial of CinnoPar in distal forearm fracture (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Clinical improvement of fracture and Radiographic improvement of fracture healing. Started Feb 2017; status: completed.

02

Drugs

CinnoPar
03

Conditions

distal forearm fracture

Beyond the preview

Go deeper on IRCT20180526039837N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180526039837N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call